Skip to main content
Premium Trial:

Request an Annual Quote

Genome Quebec Funds VIA's PGx Study in Clinical Trials for ACS Drug

NEW YORK (GenomeWeb News) - VIA Pharmaceuticals said today that it has secured funding from Genome Quebec to perform a pharmacogenomics sub-study as part of clinical trials for its lead candidate for acute coronary syndrome.
VIA said it will collaborate with the Montreal Heart Institute to perform genomics and proteomics studies and develop a genotyping panel it could use in Phase II clinical trials for its ACS drug VIA-2291.
VIA, a San Francisco-based small-molecule drug developer, estimated that the program will cost around $5 million. The company will provide around $2.4 million in funding for the ACS clinical trial, and around $200,000 for costs related to the pharmacogenomics sub-study. Genome Quebec and other companies will provide the balance of the funding, the company said.
The project will focus on development of a 5 lipoxygenase genotyping panel and an ADME/tox panel for VIA-2291, VIA said.
"We believe that this sub-study will generate important information on the pharmacogenomics of our study patients, and will provide additional insight into the role we believe VIA-2291 will play in reducing vascular inflammation in ACS patients with atherosclerosis," VIA CEO Lawrence Cohen said in a statement.

The Scan

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.

Seagull Microbiome Altered by Microplastic Exposure

The overall diversity and the composition at gut microbiome sites appear to coincide with microplastic exposure and ingestion in two wild bird species, according to a new Nature Ecology and Evolution study.

Study Traces Bladder Cancer Risk Contributors in Organ Transplant Recipients

In eLife, genome and transcriptome sequencing reveal mutation signatures, recurrent somatic mutations, and risky virus sequences in bladder cancers occurring in transplant recipients.

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.